SCHEMBL10176523

SCHEMBL10176523

C=C(C)CC/C=C/CC/C=C/CCC1=C(C)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9766940 0.79
SCHEMBL9766936 0.79
SCHEMBL17691256 0.73
SCHEMBL2627736 0.73
SCHEMBL11474838 0.72
SCHEMBL11479252 0.69 PGR (0.33)
SCHEMBL11764576 0.67 ALDH1A1 (0.33)
SCHEMBL5086158 0.66
SCHEMBL30724724 0.65 ALDH1A1 (0.35)
SCHEMBL13886351 0.65 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106036-B2 Pharmaceutical compositions-4 HARBOR BIOSCIENCES, INC. (US) 2012-01-31 US disclosed
US-20100222313-A1 PHARMACEUTICAL COMPOSITIONS-4 BIOVIE INC. 2010-09-02 US disclosed
US-7723532-B2 Pharmaceutical compositions 3 HARBOR BIOSCIENCES, INC. (US) 2010-05-25 US disclosed
US-7524835-B2 Tetrol steroids and esters HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2009-04-28 US disclosed
US-20080176824-A1 Pharmaceutical Compositions 3 BIOVIE INC. 2008-07-24 US disclosed
US-7396827-B2 Pharmaceutical compositions and treatment methods HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2008-07-08 US disclosed
US-20080045490-A1 Pharmaceutical Compositions BIOVIE INC. 2008-02-21 US disclosed